Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a studyVolkan Granit, Matthew T. Duvernay, Nizar Chahin et al.|The Lancet Neurology|2023Cited by 255
Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALSMichael Benatar, G. Garcia Gutierrez, Lanyu Zhang et al.|Neurology|2020Cited by 201